Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 4
2005 9
2006 9
2007 11
2008 16
2009 22
2010 30
2011 43
2012 53
2013 61
2014 75
2015 83
2016 120
2017 123
2018 155
2019 223
2020 242
2021 218
2022 232
2023 248
2024 280
2025 337
2026 80

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,400 results

Results by year

Filters applied: . Clear all
Page 1
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial.
Tang LL, Chen L, Xu GQ, Zhang N, Huang CL, Li WF, Mao YP, Zhou GQ, Lei F, Chen LS, Huang SH, Chen L, Chen YP, Zhang Y, Liu X, Xu C, Zhao Y, Li JB, Liu N, Xie FY, Guo R, Sun Y, Ma J. Tang LL, et al. Among authors: guo r. CA Cancer J Clin. 2025 May-Jun;75(3):203-215. doi: 10.3322/caac.21881. Epub 2025 Feb 19. CA Cancer J Clin. 2025. PMID: 39970442 Free PMC article. Clinical Trial.
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.
Liang YL, Liu X, Shen LF, Hu GY, Zou GR, Zhang N, Chen CB, Chen XZ, Zhu XD, Yuan YW, Yang KY, Jin F, Hu WH, Xie FY, Huang Y, Han F, Tang LL, Mao YP, Lu LX, Sun R, He YX, Zhou YY, Long GX, Tang J, Chen LS, Zong JF, Jin T, Li L, Lin J, Huang J, Gong XY, Zhou GQ, Chen L, Li WF, Chen YP, Xu C, Lin L, Huang SH, Huang SW, Wang YQ, Huang CL, Feng HX, Hou M, Chen CH, Zheng SF, Li YQ, Hong SB, Jie YS, Li H, Yun JP, Zang SB, Liu SR, Lin QG, Li HJ, Tian L, Liu LZ, Zhao HY, Li JB, Lin AH, Liu N, Zhang Y, Guo R, Ma J, Sun Y. Liang YL, et al. Among authors: guo r. JAMA. 2025 May 13;333(18):1589-1598. doi: 10.1001/jama.2025.1132. JAMA. 2025. PMID: 40079940 Free PMC article. Clinical Trial.
SERCA2a: a key protein in the Ca2+ cycle of the heart failure.
Zhihao L, Jingyu N, Lan L, Michael S, Rui G, Xiyun B, Xiaozhi L, Guanwei F. Zhihao L, et al. Among authors: rui g. Heart Fail Rev. 2020 May;25(3):523-535. doi: 10.1007/s10741-019-09873-3. Heart Fail Rev. 2020. PMID: 31701344 Review.
(E)-2-(2-Furylmethyl-idene)-2,3-dihydro-1H-pyrrolizin-1-one.
Ali Y, Yu P, Hua E, Rui G, Qi S. Ali Y, et al. Among authors: rui g. Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 5;66(Pt 7):o1578. doi: 10.1107/S1600536810017939. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21587819 Free PMC article.
2,400 results